{"id":6929,"date":"1970-01-01T00:00:00","date_gmt":"1970-01-01T00:00:00","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/"},"modified":"1970-01-01T00:00:00","modified_gmt":"1970-01-01T00:00:00","slug":"nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/","title":{"rendered":"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Nicox S.A. (NYSE Euronext Paris: COX) et Rapid Pathogen Screening, Inc (RPS\u00ae) annoncent aujourd\u2019hui la signature d\u2019un accord de licence donnant \u00e0 NicOx l\u2019acc\u00e8s aux tests diagnostiques innovants de RPS\u00ae. Par cet accord, Nicox obtient les droits mondiaux de tests uniques r\u00e9alisables en cabinet de consultation, dans le domaine oculaire. Le premier d\u2019entre eux est AdenoPlus\u2122 et est d\u00e9j\u00e0 autoris\u00e9 \u00e0 la vente aux Etats-Unis et en Europe. Ces tests utilisent la technologie brevet\u00e9e de RPS\u00ae et permettent au praticien de diagnostiquer rapidement et pr\u00e9cis\u00e9ment en cabinet de consultation des maladies et des troubles oculaires sp\u00e9cifiques.<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-6929","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"\nNicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox\" \/>\n<meta property=\"og:description\" content=\"Nicox S.A. (NYSE Euronext Paris: COX) et Rapid Pathogen Screening, Inc (RPS\u00ae) annoncent aujourd\u2019hui la signature d\u2019un accord de licence donnant \u00e0 NicOx l\u2019acc\u00e8s aux tests diagnostiques innovants de RPS\u00ae. Par cet accord, Nicox obtient les droits mondiaux de tests uniques r\u00e9alisables en cabinet de consultation, dans le domaine oculaire. Le premier d\u2019entre eux est AdenoPlus\u2122 et est d\u00e9j\u00e0 autoris\u00e9 \u00e0 la vente aux Etats-Unis et en Europe. Ces tests utilisent la technologie brevet\u00e9e de RPS\u00ae et permettent au praticien de diagnostiquer rapidement et pr\u00e9cis\u00e9ment en cabinet de consultation des maladies et des troubles oculaires sp\u00e9cifiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"1970-01-01T00:00:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques\",\"datePublished\":\"1970-01-01T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/\"},\"wordCount\":17,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/\",\"name\":\"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"1970-01-01T00:00:00+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox","og_description":"Nicox S.A. (NYSE Euronext Paris: COX) et Rapid Pathogen Screening, Inc (RPS\u00ae) annoncent aujourd\u2019hui la signature d\u2019un accord de licence donnant \u00e0 NicOx l\u2019acc\u00e8s aux tests diagnostiques innovants de RPS\u00ae. Par cet accord, Nicox obtient les droits mondiaux de tests uniques r\u00e9alisables en cabinet de consultation, dans le domaine oculaire. Le premier d\u2019entre eux est AdenoPlus\u2122 et est d\u00e9j\u00e0 autoris\u00e9 \u00e0 la vente aux Etats-Unis et en Europe. Ces tests utilisent la technologie brevet\u00e9e de RPS\u00ae et permettent au praticien de diagnostiquer rapidement et pr\u00e9cis\u00e9ment en cabinet de consultation des maladies et des troubles oculaires sp\u00e9cifiques.","og_url":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/","og_site_name":"Nicox","article_published_time":"1970-01-01T00:00:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/"},"author":{"name":"","@id":""},"headline":"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques","datePublished":"1970-01-01T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/"},"wordCount":17,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/","url":"https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/","name":"Nicox signe un accord de licence mondial avec Rapid Pathogen Screening, Inc. pour des tests diagnostiques ophtalmiques - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"1970-01-01T00:00:00+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-signe-un-accord-de-licence-mondial-avec-rapid-pathogen-screening-inc-pour-des-tests-diagnostiques-ophtalmiques\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=6929"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6929\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=6929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=6929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=6929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}